Cardiovascular and renal benefits of dry bean and soybean intake

American Journal of Clinical Nutrition

Volumn 70, Issue 3 SUPPL., 1999, Pages

  Anderson, James W ^a   Smith, Belinda M ^b   Washnock, Carla S ^b  

^a Medical Service   (United States)

^b NONE

Author keywords

Cardiovascular disease; Cholesterol; Diabetes; Isoflavones; Legumes; Renal function; Soy

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; DAIDZEIN; FATTY ACID; GENISTEIN; ISOFLAVONE; SOYBEAN PROTEIN;

CANCER PREVENTION; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; DIETARY FIBER; DIETARY INTAKE; FOOD COMPOSITION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; NUTRITIONAL VALUE; OBESITY; SOYBEAN;

GLYCINE MAX; PHASEOLUS (ANGIOSPERM);

EID: 0032817486     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/70.3.464s     Document Type: Conference Paper

References (154)

1. Jenkins DJA, Wolever TMS, Taylor RH, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981;34:362-6.
2. Salmeron J, Manson JE, Stampfer MJ, Colditz G, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997;277:472-7.
3. Young VR. Soy protein in relation to human protein and amino acid nutrition. JAMA 1991;91:828-35.
4. Barzel US. Dietary patterns and blood pressure. N Engl J Med 1997;337:637.
5. Anderson JW, Deakins DA, Floore TL, Smith BM, Whitis SE. Dietary fiber and coronary heart disease. Crit Rev Food Sci Nutr 1990;29:95-147.
6. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiotica: introducing the concept of prebiotics. J Nutr 1995;125:1401-12.
7. Adlercreutz CHT, Goldin BR, Gorbach SL, et al.Soybean phytoestrogen intake and cancer risk. J Nutr 1995;125:757S-70S.
8. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990;323:878-83.
9. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336:1117-24.
10. Geil PB, Anderson JW. Nutritional and health implications of dry beans: a review. J Am Coll Nutr 1994;13:549-58.
11. Haytowitz DB, Matthews RH. Legumes and legume products. Washington, DC: US Department of Agriculture, 1986:1-156.
12. Anderson JW. Plant fiber in foods. Lexington, KY: HCF Nutrition Foundation, 1990.
13. Komandi K, Dworschak E. Measurement of some antinutritive factors in meat products containing texturated vegetable protein (TVP). Nahrung 1988;32:643-8.
14. Rackis JJ, Sessa DJ, Steggerda FR, Shimimizu T, Anderson J, Pearl SL. Soybean factors relating to gas production by intestinal bacteria. J Food Sci 1970;35:635-9.
15. Hayakawa K, Mizutani J, Wada K, Masai T, Yoshihara I, Mitsuoka T. Effects of soybean oligosaccharides on human faecal flora. Microbiol Ecol Health Dis 1990;3:293-303.
16. Benno Y, Endo K, Mizutani T, Namba Y, Komori T, Mitsuoka T. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol 1989;55:1100-5.
17. Linscheer WG, Vergroesen AJ. Lipids. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. 8th ed. Philadelphia: Lea & Febiger, 1994:47-88.
18. Anderson JW, Smith BM, Gustafson NJ. Health benefits and practical aspects of high-fiber diets. Am J Clin Nutr 1994(suppl);59:1242S-7S.
19. Lo GS, Goldberg AP, Lim A, Grundhauser JJ, Anderson C, Schonfeld G. Soy fiber improves lipid and carbohydrate metabolism in primary hyperlipidemic subjects. Atherosclerosis 1986;62:239-48.
20. Anderson JW, Jones AE, Riddell-Mason S. Ten different dietary fibers have significantly different effects on serum and liver lipids of cholesterol-fed rats. J Nutr 1994;124:78-83.
21. Liener IE. Implications of antinutritional components in soybean foods. Crit Rev Food Sci Nutr 1994;34:31-67.
22. Anderson JW. Phytoestrogen effects in humans relative to risk for cardiovascular diseases, breast cancer, osteoporosis, and menopausal symptoms. In: Pavlik EJ, ed. Estrogens, progestins, and their antagonists. Boston: Birkhauser, 1996:51-71.
23. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of effects of soy protein intake on serum lipids in humans. N Engl J Med 1995;333:276-82.
24. Honore EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 1997;67:148-64.
25. Brandi ML. Ipraflavone: new insights into its mechanism of action on bone remodeling. Calcif Tissue Int 1993;52:151-2.
26. Cassidy A, Bingham S, Setchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1995;60:333-40.
27. Adlercreutz H, Hamalainen E, Gorbach S, Goldin B. Dietary phytooestrogens and menopause in Japan. Lancet 1992;339:1233-4.
28. Brzezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. J N Am Menopause Soc 1997;4:89-94.
29. Dwyer JT, Goldin RB, Saul N, Gaultieri L, Barakat S, Adkercreutz H. Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc 1994;94:739-43.
30. Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5.
31. Peterson G. Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 1995;125:784S-9S.
32. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995;208:124-30.
33. Kanazawa T, Osanai T, Zhang XS, et al. Protective effects of soy protein on the peroxidizability of lipoproteins in cerebral vascular diseases. J Nutr 1995;125:639S-46S.
34. Wang H, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994;42:1666-73.
35. Wang H, Murphy PA. Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year, and location. J Agric Food Chem 1994;42:1674-7.
36. Franke AA, Custer LJ, Cerna CM, Narala KK. Quantitation of phytoestrogens in legumes by HPLC. J Agric Food Chem 1994;42:1905-13.
37. Coward L, Barnes NC, Setchell KD, Barnes S. Genistein, daidzein, and their beta-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 1993;41:1961-7.
38. Reinli K, Block G. Isoflavone content of soy foods. Nutr Cancer 1996;26:123-48.
39. 1997 Cardiovascular Statistics. Dallas: American Heart Association, 1996.
40. Jousilahti P, Vartiainen E, Toumilehto J, Puska P. Twenty-year dynamics of serum cholesterol levels in the middle-aged population of Eastern Finland. Ann Intern Med 1996;125:713-22.
41. Dwyer J. Overview: dietary approaches for reducing cardiovascular disease risks. J Nutr 1995;125:656S-65S.
42. Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT. The primary prevention of myocardial infarction. N Engl J Med 1992;326:1406-16.
43. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-9.
44. Van Horn L. Fiber, lipids, and coronary heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997;95:2701-4.
45. Howard BV, Kritchevsky D. Phytochemicals and cardiovascular disease, a statement for healthcare professionals from the American Heart Association. Circulation 1997;95:2591-3.
46. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-16.
47. Anderson JW. Dietary fibre, complex carbohydrate and coronary heart disease. Can J Cardiol 1995;11:55G-62G.
48. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. Vegetable, fruit, and cereal intake and risk of coronary heart disease among men. JAMA 1996;275:447-51.
49. Trowell H. Ischemic heart disease and dietary fiber. Am J Clin Nutr 1972;25:926-32.
50. Pilch SM. Physiologic effects and health consequences of dietary fiber. Bethesda, MD: Federation of American Societies for Experimental Biology, 1987:36.
51. Glore SR, Van Treeck DV, Knehaus AW, Guild M. Soluble fiber and serum lipids: a literature review. J Am Diet Assoc 1994;94:425-36.
52. Morris JN, Marr JW, Clayton DG. Diet and heart: a postscript. Br Med J 1977;2:1307-14.
53. Slavin JL. Epidemiologic evidence for the impact of whole grains on health. Crit Rev Food Sci Nutr 1994;34:427-34.
54. Anderson JW, Spencer DO, Riddell-Mason S, Floore TL, Dillon DW, Oeltgen PR. Postprandial serum glucose, insulin, and lipoprotein responses to high- and low-fiber diets. Metabolism 1995;44:848-54.
55. Anderson JW, Gustafson NJ. Hypocholesterolemic effects of oat and bean products. Am J Clin Nutr 1988;48:749-53.
56. Anderson JW, Spencer DO, Hamilton CC, et al. Oat-bran cereal lowers serum total and LDL cholesterol in hypercholesterolemic men. Am J Clin Nutr 1989;52:495-9.
57. Kirby RW, Anderson JW, Selling B, et al. Oat-bran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men. Am J Clin Nutr 1981;34:824-9.
58. Marlett JA, Hosig KB, Vollendorf NW, Shinnick FL, Haack VS, Story JS. Mechanism of serum cholesterol reduction by oat bran. Hepatology 1994;20:1450-7.
59. Anderson JW. Cholesterol-lowering effects of soluble fiber in humans. In: Kritchevsky D, Bonfield C, eds. Dietary fiber in health and disease. St Paul: Eagan Press, 1995:126-45.
60. Everson GT, Daggy BP, McKinley C. Story JA. Effects of psyllium hydrophilic mucilloid on LDL-cholesterol and bile acid synthesis in hypercholesterolemic men. J Lipid Res 1992;33:1183-92.
61. Anderson JW. Short chain fatty acids and lipid metabolism: human studies. In: Cummings JH, Rombeau JL, Sakata T, eds. Physiological and clinical aspects of short chain fatty acids. New York: Cambridge University Press, 1995:509-23.
62. Bridges SR, Anderson JW, Deakins DA, Dillon DW, Wood CA. Oat bran increases serum acetate of hypercholesterolemic men. Am J Clin Nutr 1992;56:455-9.
63. Wright RS, Anderson JW, Bridges SR. Propionate inhibits hepatocyte lipid synthesis. Proc Soc Exp Biol Med 1990;195:26-9.
64. Morita T, Oh-hashi A, Takei K, Ikai M, Kasoaka S, Kiriyama S. Cholesterol-lowering effects of soybean, potato, and rice proteins depend on their low methionine contents in rats fed a cholesterolfree purified diet. J Nutr 1997;127:470-7.
65. Carroll KK. Hypocholesterolemia and atherosclerosis: effects of dietary protein. Fed Proc 1982;41:2792-6.
66. Hodges RE, Krehl WA, Stone DB, Lopez A. Dietary carbohydrates and low cholesterol diets: effects on serum lipids on man. Am J Clin Nutr 1967;20:198-208.
67. Vahouny GV, Adamson I, Chalcarz W, et al. Effects of casein and soy protein on hepatic and serum lipids and lipoprotein lipid distribution in the rat. Atherosclerosis 1985;56:127-37.
68. Lovati MR, Manzoni C, Corsini A, Granata A, Fumagalli R, Sirtori CR. 7S globulin from soybean is metabolized in human cell cultures by a specific uptake and degradation system. J Nutr 1996;126:2831-42.
69. Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM, Burke GL. Soy isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996;126:43-50.
70. Sirtori CR, Gianazza E, Manzoni C, Lovati MR, Murphy PA. Role of isoflavones in the cholesterol reduction by soy proteins in the clinic. Am J Clin Nutr 1997;65:166-7.
71. Potter S. Overview of proposed mechanisns for the hypocholesterolemic effect of soy. J Nutr 1996;125:606S-11S.
72. Huff MW, Giovannetti PM, Wolfe BM. Turnover of very low-density lipoprotein-apoprotein B is increased by substitution of soybean protein for meat and dairy protein in the diets of hypercholesterolemic men. Am J Clin Nutr 1984;39:888-97.
73. Lovati MR, Manzoni C, Canavesi A, et al. Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 1987;80:1498-502.
74. Raines EW, Ross R. Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the potential impact of soy. J Nutr 1995;125:624S-30S.
75. Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995;125:790S-7S.
76. Clarkson TB, Anthony MS, Klein KP. Effect of estrogen treatment on arterial wall structure and function. Drugs 1994;47:42-51.
77. Williams JK and Clarkson TB. Dietary soy isoflavones inhibit in-vitro constrictor responses of coronary arteries to collagen-induced platelet activation. Coron Artery Dis 1998;9:759-64.
78. Wilcox JN, Blumenthal BF. Thrombotic mechanisms in atherosclerosis: potential impact of soy proteins. J Nutr 1995;125:631S-8S.
79. Goodenham MJ, Adlercreutz H, Ojala ST, Wahala K, Holub BJ. A soy protein isolate rich in genistein and daidzen and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids a fatty acid composition of plasma phospholipids in normal men. J Nutr 1996;126:2000-6.
80. Koh KK, Mincemower R, et al. Effect of hormone-replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med 1997;336:683-90.
81. Gebara OCE, Mittleman MA, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 1995;91:1952-8.
82. Navab M, Berliner JA, Watson AD, et al. The yin and yang of oxidation in the development of the fatty streak. Arterioscler Thromb Vasc Biol 1996;16:831-42.
83. Hodgson JM, Croft KD, Puddey IB, Mori TA, Beilin LJ. Soybean isoflavonoids and their metabolites inhibit in vitro lipoprotein oxidation in serum. J Nutr Biochem 1996;7:664-9.
84. Sack MN, Rader DJ, Cannon RO III. Oestrogens and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269-70.
85. Kay R, Wong KS, Yu YL, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588-93.
86. Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995;332:512-21.
87. Kistler JP. The risk of embolic stroke: another piece of the puzzle. N Engl J Med 1994;331:1517-9.
88. Ball M, Robertson I. Does diet influence stroke incidence? N Z Med J 1994;107:395-6.
89. Khaw K-T, Barrett-Connor E. Dietary potassium and stroke-associated mortality: a 12-year prospective population study. N Engl J Med 1987;316:235-40.
90. Wilson PWF, Hoeg JM, D'Agostino RB, et al. Cumulative effect of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med 1997;337:516-22.
91. Crouse JR, Byington RP, Hoen HM, Furberg CD. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med 1997;157:1305-10.
92. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993;119:655-60.
93. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994;272:205-11.
94. Wadden TA, Sternberg JA, Letizia KA, Stunkard AJ, Foster GD. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective. Int J Obes 1989;13:39-46.
95. Anderson JW, Bryant CA. Dietary fiber: diabetes and obesity. Am J Gastroenterol 1986;81:898-906.
96. Smith U. Dietary fibre, diabetes and obesity. Int J Obes 1987;11:27-31.
97. Levine AS, Tallman JR, Grace MK, Parker SA, Billington CJ, Levitt MD. Effect of breakfast cereal on short-term food intake. Am J Clin Nutr 1989;50:1303-7.
98. Rolls BJ. Carbohydrates, fats, and satiety. Am J Clin Nutr 1995;61(suppl):960S-7S.
99. Hill AJ, Blundell JE. Macronutrients and satiety: the effects of a high-protein or high-carbohydrate meal on subjective motivation to eat and food preferences. Nutr Behav 1986;3:133-44.
100. Barkeling B, Rossner S, Bjorvell H. Effects of a high-protein meal (meat) and a high-carbohydrate meal (vegetarian) on satiety measured by automatic computerized monitering of subsequent food intake, motivation to eat and food preferences. Int J Obes 1990;14:743-51.
101. Hannah JS, Dubey AK, Hansen BC. Postingestinal effects of a high-protein diet on the regulation of food intake in monkeys. Am J Clin Nutr 1990;52:320-5.
102. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-9.
103. Anderson JW, Blake JE, Turner J, Smith BM. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 1998;68(suppl):1347-53.
104. Kontessis P, Jones SL, Dodds R, et al. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 1990;38:136-44.
105. Pecis M, de Azevedo M, Gross JL. Chicken and fish diet reduces glomerular hyperfiltration in IDDM patients. Diabetes Care 1994;17:665-72.
106. Everhart JE, Pettitt D, Bennett PH, Knowler WC. Duration of obesity increases the incidence of NIDDM. Diabetes 1992;41:235-40.
107. Salmeron J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load, and risk for NIDDM in men. Diabetes Care 1997;20:545-50.
108. Marshall JA, Hamman RF, Baxter J. High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: The San Luis Valley Diabetes Study. Am J Epidemiol 1991;134:590-603.
109. Anderson JW, Akanji AO. Dietary fiber: an overview. Diabetes Care 1991;14:1126-31.
110. Anderson JW, Zeigler JA, Deakins DA, et al. Metabolic effects of high-carbohydrate, high-fiber diets for insulin-dependent diabetic individuals. Am J Clin Nutr 1991;54:936-43.
111. Fukagawa NK, Anderson JW, Hageman G, Young VR, Minaker KL. High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults. Am J Clin Nutr 1990;52:524-8.
112. Panlasigui LN, Panlilio LM, Madrid JC. Glycaemic response in normal subjects to five different legumes commonly used in the Philippines. Int J Food Sci Nutr 1995;46:155-60.
113. Potter JD, Steinmetz K. Vegetables, fruit and phytoestrogens as preventive agents. In: Stewart BW, McGregor D, Kleihues P, eds. Principles of chemoprevention. Lyon, France: International Agency for Research on Cancer, 1996:61-90.
114. Weisburger J. Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids. Am J Clin Nutr 1991;53:226S-37S.
115. Block G, Patterson B, Subar A. Fruits, vegetables, and cancer prevention: a review of the epidemiologic evidence. Nutr Cancer 1992;18:1-29.
116. Byers T, Perry G. Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Annu Rev Nutr 1992;12:139-59.
117. Goodman MT, Wilkens LR, Hankin JH, Lyu L, Wu AH, Kolonel LN. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 1997;146:294-306.
118. Ghadirian P, Lacroix A, Maisonneuve P, et al. Nutritional factors and colon cancer: a case-control study involving French Canadians in Montreal, Quebec, Canada. Cancer 1997;80:848-64.
119. Messina MJ, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994;21:113-31.
120. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995;125:777S-83S.
121. Hawrylewicz EJ, Zapata JJ, Blair WH. Soy and experimental cancer: animal studies. J Nutr 1995;125:698S-708S.
122. Kennedy AR. The evidence for soybean products as cancer preventive agents. J Nutr 1995;125:733S-43S.
123. Nishio K, Miura K, Ohira T, Heike Y, Saijo N. Genistein, a tyrosine kinase inhibitor, decreased the affinity of p56-lck to beta-chain of interleukin-2 receptor in human natural killer (NK)-rich cells and decreased NK-mediated cytotoxicity. Proc Soc Exp Biol Med 1994;207:227-33.
124. Steele VE, Pereira MA, Sigman CC, Kelloff GL. Cancer chemoprevention agent development strategies for genistein. J Nutr 1995;125:713S-6S.
125. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study off phyto-oestrogens and breast cancer. Lancet 1997;350:990-4.
126. Urban D, Grizzie WE, Coward L, Kirk M, Barnes S. A clinical trial of the chemopreventive effect of a soy beverage in men at high risk for prostate cancer. J Nutr 1995;125:800S (abstr).
127. Jibani MM, Bloodworth LL, Foden E, et al. Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: early effects on albumin excretion rate and nutritional status. Diabetes Med 1991;8:949-53.
128. Zeller KR. Low-protein diets in renal disease. Diabetes Care 1991;14:856-66.
129. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effects of dietary protein restriction on the progression of diabetic and non-diabetic renal disease: a meta-analysis. Ann Intern Med 1996;124:627-32.
130. Nakamura H, Takasawa M, Kasahara S, et al. Effects of acute protein loads of different sources on renal function of patients with diabetic nephropathy. Tohoku J Exp Med 1989;159:153-62.
131. Chan AYM, Cheng MLL, Keil LC, Myers BD. Functional response of healthy and diseased glomeruli to a large, protein-rich meal. J Clin Invest 1988;81:245-54.
132. Williams AJ, Balo F, Walls J. Effect of varying quantity and quality of dietary protein intake in experimental renal disease in rats. Nephron 1987;46:83-90.
133. D'Amico G, Gentile MG. Influence of diet on lipid abnormalities in human renal disease. Am J Kidney Dis 1993;22:151-7.
134. Barsotti G, Navelesi R, Giampietro O, et al. Effects of a vegetarian, supplemented diet on renal function, proteinuria, and glucose metabolism in patients with 'overt' diabetic nephropathy and renal insufficiency. Contrib Nephrol 1988;65:87-94.
135. Trevisan R, Viberti GC. Pathophysiology of diabetic nephropathy. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes mellitus. Philadelphia: Lippincott-Raven, 1996:727-37.
136. Breyer JA. Diabetic nephropathy in insulin-dependent patients. Am J Kidney Dis 1992;20:533-47.
137. Nowack R, Raum E, Blum W, Ritz E. Renal hemodynamics in recent-onset type II diabetes. Am J Kidney Dis 1992;20:342-7.
138. Carr S, Mbanya J, Thomas T, et al. Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport. N Engl J Med 1990;322:500-5.
139. Jones SL, Kontessis P, Wiseman M, et al. Protein intake and blood glucose as modulators of GFR in hyperfiltering diabetic patients. Kidney Int 1992;41:1620-8.
140. Wiseman MJ, Mangili R, Alberetto M, Keen H, Viberti GC. Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics. Kidney Int 1997;31:1012-8.
141. Fioretto P, Trevisan R, Valerio A, et al. Impaired renal response to a meat meal in insulin-dependent diabetes: role of glucagon and prostaglandins. Am J Physiol 1990;258:F675-83.
142. Evanof G, Thompson C, Brown J, Weinman E. Prolonged dietary protein restriction in diabetic nephropathy. Arch Intern Med 1989;149:1129-33.
143. Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991;324:78-84.
144. Anderson JW. Why do diabetic individuals eat so much protein and fat? Med Exerc Nutr Health 1993;2:65-8.
145. Anderson JW, Geil PB. Nutritional management of diabetes mellitus. In: Shils MW, Olson JA, Shike M, eds. Modern nutrition in health and disease. 8th ed. Philadelphia: Lea & Febiger, 1994:1259-86.
146. Riggs BL. A new option for treating osteoporosis. N Engl J Med 1990;323:124-5.
147. Licata AA. Prevention and osteoporosis management. Cleve Clin J Med 1994;61:451-60.
148. Brandi ML. Flavonoids: biochemical effects and therapeutic applications. Bone Miner 1992;19:S3-S14.
149. Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996;126:161-7.
150. Anderson JJ, Ambrose WW, Gamer SC. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med 1998;217:345-50.
151. Potter SM, Baum JA, Teng H, Stillman RJ, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone mineral density in postmenopausal women. Am J Clin Nutr 1998;68(suppl):1375S-9S.
152. Murkies AL, Lombard C, Strauss BJG, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases post-menopausal hot flashes: effect of soy and wheat. Maturitas 1995;21:189-95.
153. Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-90.
154. Knight DC, Wall PL, Eden JA. A review of phytoestrogens and their effects in relation to menopausal symptoms. Aust J Nutr Diet 1996;53:5-11.